[1]
Sałacki AJ, Wysokiński A. Reactive thrombocytosis resulting from frequent blood donations as an extremely rare cause of ST Segment Elevation Myocardial Infarction in the case of a 19-year-old male. Annals of agricultural and environmental medicine : AAEM. 2018 Dec 20:25(4):602-604. doi: 10.26444/aaem/74196. Epub 2017 Jul 15
[PubMed PMID: 30586983]
Level 3 (low-level) evidence
[3]
Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood. 2017 Feb 9:129(6):680-692. doi: 10.1182/blood-2016-10-695957. Epub 2016 Dec 27
[PubMed PMID: 28028026]
[4]
Bleeker JS, Hogan WJ. Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies. Thrombosis. 2011:2011():536062. doi: 10.1155/2011/536062. Epub 2011 Jun 8
[PubMed PMID: 22084665]
[5]
Buss DH, Cashell AW, O'Connor ML, Richards F 2nd, Case LD. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. The American journal of medicine. 1994 Mar:96(3):247-53
[PubMed PMID: 8154513]
Level 3 (low-level) evidence
[6]
Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z. Postsplenectomy reactive thrombocytosis. Proceedings (Baylor University. Medical Center). 2009 Jan:22(1):9-12
[PubMed PMID: 19169391]
[7]
McMullin MF. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis. Hematology. American Society of Hematology. Education Program. 2019 Dec 6:2019(1):391-396. doi: 10.1182/hematology.2019000047. Epub
[PubMed PMID: 31808840]
[8]
Zheng SY, Xiao QY, Xie XH, Deng Y, Ren L, Tian DY, Luo ZX, Luo J, Fu Z, Huang AL, Liu EM. Association between secondary thrombocytosis and viral respiratory tract infections in children. Scientific reports. 2016 Mar 11:6():22964. doi: 10.1038/srep22964. Epub 2016 Mar 11
[PubMed PMID: 26965460]
[9]
Indolfi G, Catania P, Bartolini E, Azzari C, Massai C, Poggi GM, De Martino M, Resti M. Incidence and clinical significance of reactive thrombocytosis in children aged 1 to 24 months, hospitalized for community-acquired infections. Platelets. 2008 Sep:19(6):409-14. doi: 10.1080/09537100802233107. Epub
[PubMed PMID: 18925508]
[11]
Araneda M, Krishnan V, Hall K, Kalbfleisch J, Krishnaswamy G, Krishnan K. Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. Southern medical journal. 2001 Apr:94(4):417-20
[PubMed PMID: 11332909]
[12]
Scharf RE. Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment. Hamostaseologie. 2016 Nov 7:36(4):241-260
[PubMed PMID: 27414763]
[13]
Kulnigg-Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldhör T, Evstatiev R, Kamali H, Volf I, Gasche C. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflammatory bowel diseases. 2013 Jul:19(8):1609-16. doi: 10.1097/MIB.0b013e318281f4db. Epub
[PubMed PMID: 23644823]
Level 1 (high-level) evidence
[14]
Jimenez K, Kulnigg-Dabsch S, Gasche C. Management of Iron Deficiency Anemia. Gastroenterology & hepatology. 2015 Apr:11(4):241-50
[PubMed PMID: 27099596]
[15]
Alberio L. Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice. Hamostaseologie. 2016 Nov 7:36(4):227-240
[PubMed PMID: 25707870]
[16]
Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World journal of surgery. 2012 Jan:36(1):192-200. doi: 10.1007/s00268-011-1329-7. Epub
[PubMed PMID: 22045447]
[17]
Schafer AI. Thrombocytosis: too much of a good thing? Transactions of the American Clinical and Climatological Association. 2002:113():68-76; discussion 76-7
[PubMed PMID: 12053719]